Currently, outcome of kidney transplantation is generally good on the short term, and large numbers of patients benefit from the achievements and improvements of the past 70 years. However, two main issues hamper the success of human-to-human kidney transplantation as treatment of kidney failure:
– Scarcity of human organs
– Donor-recipient incompatibility
During this webinar, the group of panelists discuss the need and promises of such futuristic transplantations. The panelists debate, very practically, patient selection strategies and endpoints for xenotransplantation.
Let’s get prepped for the future!
Lorna Marson, Edinburgh, UK
Stefan Schneeberger, Innsbruck, Austria
Emanuele Cozzi, Padua, Italy
Richard N. Pierson III, Boston, USA
Bruno Reichart, Munich, Germany
Linda Scobie, Glasgow, UK
– When will xenotransplantation be called a success?
– Xenotransplantation for heart failure: how close are we?
– Overcoming the regulatory hurdles for xenotransplantation
– Patient selection for clinical xenotransplant trials
This webinar is part of the preparatory activities to the TLJ 2.0 programme.
The webinar is organised by the working group WS01, focusing on “New Surrogate endpoints in transplantation“. For more information on TLJ 2.0 activities please visit www.tlj-esot.org